image
Healthcare - Biotechnology - NASDAQ - US
$ 2.85
1.42 %
$ 23.9 M
Market Cap
-1.1
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-25.7 M OPERATING INCOME
55.37%
-20.8 M NET INCOME
61.57%
EFFICIENCY
Earnings Waterfall Lisata Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 189 K
Gross Profit -189 K
Operating Expenses 25.7 M
Operating Income -25.7 M
Other Expenses -4.87 M
Net Income -20.8 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Sep-1990
REVENUE
Revenue 0 121.4 0 0 0 0 0 35.3 22.5 17.9 14.7 14.3 10.1 69.8 11.6 83.5 K 0.2 45.7 K 35.3 K 48.6 K 64.6 K 81.3 K 0.1 0.5 12.9 K 0 0 0 21.1 7.6 0.3 4.5
GROSS PROFIT
Cost Of Revenue 0.2 57.6 55 K 63 K 65 K 0.2 0.4 31.1 20.2 15.7 12.9 11.9 8.6 49.7 7.6 32 K 24.8 K 22.4 K 24.8 K 33.9 K 43.6 K 60.6 K 70.7 K 0.1 74.8 K 0 0 0 15.5 0 0 1.4
Gross Profit (0.2) 63.8 55 K 63 K 65 K (0.2) (0.4) 4.1 2.3 2.3 1.7 2.4 1.4 20.2 4.0 51.6 K 0.2 23.3 K 10.5 K 14.7 K 21 K 20.8 K 36.8 K 0.4 87.6 K 0 0 0 5.5 7.6 0.3 3.1
OPERATING INCOME
Operating Expenses 25.7 57.6 29.1 19.1 20.1 17.0 27.6 35.5 53.9 60.0 38.5 32.8 35.4 39.0 27.8 9.3 10.6 4.7 1.6 1.5 0.9 1.2 1.6 2.7 1.1 0 0.3 0.3 8.3 7.4 0.3 4.6
Selling, General and Administrative Expenses 13.0 14.1 11.4 9.9 9.3 9.4 11.8 20.4 30.0 30.8 21.6 22.3 27.7 31.3 23.5 9.3 10.6 4.7 1.6 0.8 0.7 0.9 1.6 2.6 1.1 0 0.3 0.3 8.3 7.4 0.3 3.2
Research and Development Expenses 12.7 43.5 17.7 9.3 10.8 7.6 15.8 15.1 23.9 29.2 16.9 10.5 7.7 7.7 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.3
Operating Income (25.7) (57.6) (29.1) (19.1) (20.1) (17.0) (27.6) (31.3) (113.8) (57.7) (36.8) (30.4) (34.0) (18.9) (23.8) (9.2) (10.4) (4.7) (1.6) (1.5) (0.9) (1.1) (1.6) (2.3) (1.1) 0 (0.3) (0.3) (3.9) 0.2 20 K (1.5)
PRE-TAX INCOME
Interest Income Expense 0 (1.9) 0 0 0 5 K 0.4 1.9 2.1 0.8 0.3 1.6 2.6 0.5 91.3 K 11.7 K 22 K 1.4 0.1 0 0.2 0 0 10.1 K 0 0 0 0 (0.5) (0.2) 0 (0.3)
Total Other Income 2.5 0.9 76 K 0.1 0.7 0.8 (0.1) 78 K 15.6 2.2 (1.9) (5.9) (0.6) 32.2 K 2.0 8.62 K 6.64 K (1.4) (0.1) (0.7) (0.2) (0.3) (0.3) 0.3 0 0 17.4 K 3.64 K 0.5 0 0 (0.5)
Pre-Tax Income (23.2) (56.7) (29.0) (19.0) (19.4) (16.2) (27.7) (33.2) (98.3) (55.6) (38.7) (36.3) (56.2) (18.8) (23.8) 0 0 0 0 (2.2) (1.1) (1.5) (1.9) (2.2) 0 0 (0.3) (0.3) (3.4) 0 20 K (2.0)
NET INCOME
Tax Provision (2.3) (2.5) (1.5) (10.9) 0.7 1 K (11.5) 0.1 (17.2) (0.1) 0.8 (0.2) 0.4 0.6 0.3 3.04 K 6.64 K 20.4 K 137 1.0 0.1 0.3 0.7 (0.4) 57 K 0 81 K (2.0) 10 K 0 20 K 0.8
Net Income (20.8) (54.2) (27.5) (8.1) (20.1) (16.2) 23.0 (32.7) (80.9) (54.9) (39.0) (53.8) (47.1) (23.3) (25.3) (9.2) (10.4) (6.1) (1.7) (1.7) (1.0) (1.2) (2.0) (2.0) (1.1) 0 (0.3) 1.7 (3.4) 0 0 (2.7)
EPS 2.58 10.5 7.45 7.91 29.2 25 38.4 74.8 250 251 285 583 798 677 2.91 K 2.29 K 4.77 K 4.37 K 3.71 K 6.4 K 5.97 K 7.78 K 13.7 K 13.7 K 13.4 K 0 20.8 K 0.1 14 K 0 0 11.2 K